Sporos Bioventures logo

Sporos Bioventures

North America, Texas, United States, Houston

Description

Sporos Bioventures is a biotechnology firm that aims to catalyze the rapid and accurate development of cancer and immune disease treatments.

Investor Profile

Sporos Bioventures has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Service Industry
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sporos Bioventures frequently co-invest with?

6C
North America, New York, United States, New York
Co-Investments: 1
Sante Ventures
North America, Texas, United States, Austin
Co-Investments: 1
PC
North America, New York, United States, New York
Co-Investments: 1
SP
North America, New York, United States, New York
Co-Investments: 1
ArrowMark Partners
North America, Colorado, United States, Denver
Co-Investments: 1
THE CATALYTIC IMPACT FOUNDATION (CIF)
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Sporos Bioventures?

Tvardi Therapeutics

Houston, Texas, United States

Tvardi Therapeutics is a Private, Clinical Stage Biotechnology Company.

BiotechnologyHealth CarePharmaceuticalService Industry
Series BJun 15, 2021
Amount Raised: $72,418,254
Nirogy Therapeutics

Natick, Massachusetts, United States

Nirogy Therapeutics is focusing on small-molecule drugs that target the solute carrier family of transporter proteins (SLCTs).

BiopharmaBiotechnologyPharmaceutical
Series AJan 26, 2021
Amount Raised: $16,500,000